229 related articles for article (PubMed ID: 23975730)
1. Anticholinergic component of the Drug Burden Index and the Anticholinergic Drug Scale as measures of anticholinergic exposure in older people in New Zealand: a population-level study.
Narayan SW; Hilmer SN; Horsburgh S; Nishtala PS
Drugs Aging; 2013 Nov; 30(11):927-34. PubMed ID: 23975730
[TBL] [Abstract][Full Text] [Related]
2. Associations of drug burden index with falls, general practitioner visits, and mortality in older people.
Nishtala PS; Narayan SW; Wang T; Hilmer SN
Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):753-8. PubMed ID: 24723335
[TBL] [Abstract][Full Text] [Related]
3. Anticholinergic and sedative drug burden in community-dwelling older people: a national database study.
Byrne CJ; Walsh C; Cahir C; Ryan C; Williams DJ; Bennett K
BMJ Open; 2018 Jul; 8(7):e022500. PubMed ID: 29982221
[TBL] [Abstract][Full Text] [Related]
4. The Association Between Drug Burden Index (DBI) and Health-Related Outcomes: A Longitudinal Study of the 'Oldest Old' (LiLACS NZ).
Cardwell K; Kerse N; Ryan C; Teh R; Moyes SA; Menzies O; Rolleston A; Broad J; Hughes CM
Drugs Aging; 2020 Mar; 37(3):205-213. PubMed ID: 31919805
[TBL] [Abstract][Full Text] [Related]
5. Measuring anticholinergic drug exposure in older community-dwelling Australian men: a comparison of four different measures.
Pont LG; Nielen JT; McLachlan AJ; Gnjidic D; Chan L; Cumming RG; Taxis K
Br J Clin Pharmacol; 2015 Nov; 80(5):1169-75. PubMed ID: 25923961
[TBL] [Abstract][Full Text] [Related]
6. Anticholinergic drug use in elderly people: A population- based study in Iran.
Raei K; Rahimi A; Hosseini SR; Moghadamnia AA; Bijani A
Caspian J Intern Med; 2021; 12(4):593-599. PubMed ID: 34820068
[TBL] [Abstract][Full Text] [Related]
7. Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline.
Kashyap M; Belleville S; Mulsant BH; Hilmer SN; Paquette A; Tu le M; Tannenbaum C
J Am Geriatr Soc; 2014 Feb; 62(2):336-41. PubMed ID: 24417438
[TBL] [Abstract][Full Text] [Related]
8. Comparative Associations Between Measures of Anti-cholinergic Burden and Adverse Clinical Outcomes.
Hsu WH; Wen YW; Chen LK; Hsiao FY
Ann Fam Med; 2017 Nov; 15(6):561-569. PubMed ID: 29133497
[TBL] [Abstract][Full Text] [Related]
9. Anticholinergic burden in older women: not seeing the wood for the trees?
Parkinson L; Magin PJ; Thomson A; Byles JE; Caughey GE; Etherton-Beer C; Gnjidic D; Hilmer SN; Lo TK; McCowan C; Moorin R; Pond CD
Med J Aust; 2015 Feb; 202(2):91-4. PubMed ID: 25627741
[TBL] [Abstract][Full Text] [Related]
10. Anticholinergic medicines use among older adults before and after initiating dementia medicines.
Narayan SW; Pearson SA; Litchfield M; Le Couteur DG; Buckley N; McLachlan AJ; Zoega H
Br J Clin Pharmacol; 2019 Sep; 85(9):1957-1963. PubMed ID: 31046175
[TBL] [Abstract][Full Text] [Related]
11. Anticholinergic medicines in an older primary care population: a cross-sectional analysis of medicines' levels of anticholinergic activity and clinical indications.
Magin PJ; Morgan S; Tapley A; McCowan C; Parkinson L; Henderson KM; Muth C; Hammer MS; Pond D; Mate KE; Spike NA; McArthur LA; van Driel ML
J Clin Pharm Ther; 2016 Oct; 41(5):486-92. PubMed ID: 27349795
[TBL] [Abstract][Full Text] [Related]
12. Anticholinergics: theoretical and clinical overview.
Nishtala PS; Salahudeen MS; Hilmer SN
Expert Opin Drug Saf; 2016 Jun; 15(6):753-68. PubMed ID: 26966981
[TBL] [Abstract][Full Text] [Related]
13. Patterns of Dementia Treatment and Frank Prescribing Errors in Older Adults With Parkinson Disease.
Mantri S; Fullard M; Gray SL; Weintraub D; Hubbard RA; Hennessy S; Willis AW
JAMA Neurol; 2019 Jan; 76(1):41-49. PubMed ID: 30285047
[TBL] [Abstract][Full Text] [Related]
14. Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people.
Salahudeen MS; Hilmer SN; Nishtala PS
J Am Geriatr Soc; 2015 Jan; 63(1):85-90. PubMed ID: 25597560
[TBL] [Abstract][Full Text] [Related]
15. Audit of anticholinergic medication changes in older hospitalised patients using the Anticholinergic Drug Scale.
Lee MSS; Hanger HC
Intern Med J; 2017 Jun; 47(6):689-694. PubMed ID: 28229530
[TBL] [Abstract][Full Text] [Related]
16. Concordance Between Anticholinergic Burden Scales.
Naples JG; Marcum ZA; Perera S; Gray SL; Newman AB; Simonsick EM; Yaffe K; Shorr RI; Hanlon JT;
J Am Geriatr Soc; 2015 Oct; 63(10):2120-4. PubMed ID: 26480974
[TBL] [Abstract][Full Text] [Related]
17. Deprescribing anticholinergic and sedative medicines: protocol for a Feasibility Trial (DEFEAT-polypharmacy) in residential aged care facilities.
Ailabouni N; Mangin D; Nishtala PS
BMJ Open; 2017 Apr; 7(4):e013800. PubMed ID: 28416498
[TBL] [Abstract][Full Text] [Related]
18. Drug Burden Index and hospitalization among community-dwelling older people.
Lönnroos E; Gnjidic D; Hilmer SN; Bell JS; Kautiainen H; Sulkava R; Hartikainen S
Drugs Aging; 2012 May; 29(5):395-404. PubMed ID: 22530705
[TBL] [Abstract][Full Text] [Related]
19. Drug Burden Index and Its Association With Hip Fracture Among Older Adults: A National Population-Based Study.
Jamieson HA; Nishtala PS; Scrase R; Deely JM; Abey-Nesbit R; Hilmer SN; Abernethy DR; Berry SD; Mor V; Lacey CJ; Schluter PJ
J Gerontol A Biol Sci Med Sci; 2019 Jun; 74(7):1127-1133. PubMed ID: 30084928
[TBL] [Abstract][Full Text] [Related]
20. Drug Burden Index and change in cognition over time in community-dwelling older men: the CHAMP study.
Jamsen KM; Gnjidic D; Hilmer SN; Ilomäki J; Le Couteur DG; Blyth FM; Handelsman DJ; Naganathan V; Waite LM; Cumming RG; Bell JS
Ann Med; 2017 Mar; 49(2):157-164. PubMed ID: 27763767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
